发明名称 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE (IDO)
摘要 There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
申请公布号 US2016022619(A1) 申请公布日期 2016.01.28
申请号 US201414776035 申请日期 2014.03.12
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 Balog James Aaron;Huang Audris;Chen Bin;Chen Libing;Seitz Steven P.;Hart Amy C.;Markwalder Jay A.
分类号 A61K31/196;A61K31/505;A61K31/44;A61K31/41;A61K31/4245;A61K31/42;A61K31/36;A61K31/27;A61K31/216;A61K31/18;C07D239/42;C07D241/42;C07D213/84;C07D213/75;C07D271/12;C07D261/14;C07D257/04;C07D317/66;C07C271/28;C07C69/743;C07C275/42;C07C311/47;A61K45/06;C07C233/55;A61N5/10;A61K31/498 主分类号 A61K31/196
代理机构 代理人
主权项 1. A compound of formula (I)where X is E is NH or CH2; W is N or CR10; Y is N or CR11; V is N or CR12;is an optionally substituted C3-C8 cycloalkyl; R1 is optionally substituted aryl, optionally substituted aryl-C1-C10-alkyl, or optionally substituted C1-C10 alkyl; R2 is COOH, optionally substituted heteroaryl or optionally substituted —CONHSO2R14; R3 is H, optionally substituted C1-C10 alkyl or halo; R4 is H, optionally substituted C1-C10 alkyl, or halo; R6 is H; R7 and R8 are independently selected from optionally substituted C1-C10 alkyl, optionally substituted C1-C10 alkoxy, optionally substituted C1-C10-alkoxy-C1-C10-alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted aryl, optionally substituted aryl-C1-C10-alkyl, optionally substituted heteroaryl, optionally substituted C2-C10 alkenyl, optionally substituted C2-C10 alkynyl, or optionally substituted C4-C8 cycloalkenyl; R9 is optionally substituted aryl, optionally substituted C1-C10 alkylaryl, optionally substituted C3-C8 cycloalkylaryl, optionally substituted C1-C10 alkoxyaryl, optionally substituted C1-C10 alkyl heteroaryl, optionally substituted heteroaryl, or optionally substituted R10 is H or halo; R11 is H or halo; and R12 is H, optionally substituted C1-C10 alkyl, or optionally substituted C2-C10 alkenyl; R14 is CF3, optionally substituted C3-C8 cycloalkyl or optionally substituted C1-C10 alkyl; and/or a stereoisomer, tautomer or a pharmaceutically acceptable salt thereof.
地址 Princeton NJ US